Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance.
- NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance.
- NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_assertion evidence source_evidence_literature NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance.
- NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_assertion SIO_000772 7923570 NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance.
- NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_assertion wasDerivedFrom befree-2016 NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance.
- NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_assertion wasGeneratedBy ECO_0000203 NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance.